It is hard to believe that rare diseases won’t take up a bigger proportion of biopharma R&D dollars in the future
Share to linkedin
Another driver for portfolio remodeling is the fact that companies are tiring of running major outcome studies required in some therapeutic areas for generating a successful product. For example, to justify to the medical community the importance of a new drug to lower plasma glucose, companies now need to run large outcomes studies to demonstrate that their new medicine not only lowers diabetes biomarkers but that it also reduces heart attacks and strokes.
इंडिया ताज़ा खबर, इंडिया मुख्य बातें
Similar News:आप इससे मिलती-जुलती खबरें भी पढ़ सकते हैं जिन्हें हमने अन्य समाचार स्रोतों से एकत्र किया है।
A rare deterrent to limitless drug price increases may die under TrumpDespite the president’s rhetoric on costs, the Commerce Department has proposed a curb on federal licensing power.
और पढो »
Office workers in China organise a rare online labour movementToiling 9am to 9pm, six days a week has become an unspoken rule in the frenetic world of Chinese tech
और पढो »
Exclusive: In rare move, French warship passes through Taiwan StraitA French warship passed through the strategic Taiwan Strait this month, U.S. off...
और पढो »
Why Pakistan lets Arab bigwigs set falcons on rare birdsThe Asian houbara is an unlikely diplomatic asset for Pakistan
और पढो »
Boeing suffers rare drop in earnings amid uncertain timeline for return of 737 MaxBoeing reported a drop in earnings and sales, as the company acknowledged that concerns over the safety of its 737 Max airplanes are taking a toll on its business.The aerospace giant said first-quarter earnings fell 10% to $3.75 per share, their biggest year-over-year decline since late 2017.
और पढो »
What these rare images of 19th-century India tell us about colonial rule'It was not meant to be shown as a grand former empire, but as these crumbling ruins.' What these rare images of 19th-century India tell us about colonial rule and how photography was used as a propaganda tool via CNNStyle
और पढो »
Tesla's Musk takes on Panasonic in a rare public battle with a key supplierElon Musk has engaged in Twitter spats with a long line of folks, from rival automakers to short sellers and the Securities and Exchange Commission. He’s at it again, this time with a crucial supplier: Panasonic Corp.
और पढो »
Japan PM Abe's ruling bloc suffers rare losses in two by-electionsJapanese Prime Minister Shinzo Abe's ruling bloc suffered two rare losses i...
और पढो »
Teachers at a D.C. charter school are trying to unionize, in a rare moveMundo Verde Bilingual Public Charter could be the only unionized charter school next year.
और पढो »